Runnymede Capital Advisors, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 1,782 shares of XBI stock, worth $153,198. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,782Holding current value
$153,198% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
916Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$959 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$874 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$821 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$732 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$689 Million0.06% of portfolio